VERITTI, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 4.978
EU - Europa 988
AS - Asia 468
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 6.446
Nazione #
US - Stati Uniti d'America 4.947
UA - Ucraina 314
IT - Italia 209
SG - Singapore 187
CN - Cina 164
DE - Germania 146
FI - Finlandia 90
IE - Irlanda 87
TR - Turchia 68
SE - Svezia 53
GB - Regno Unito 32
CA - Canada 29
IN - India 21
VN - Vietnam 20
BE - Belgio 15
NL - Olanda 13
PL - Polonia 9
JP - Giappone 6
TG - Togo 6
AT - Austria 5
RU - Federazione Russa 4
CH - Svizzera 3
AU - Australia 2
EU - Europa 2
LU - Lussemburgo 2
RO - Romania 2
BG - Bulgaria 1
BO - Bolivia 1
EG - Egitto 1
ES - Italia 1
FR - Francia 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
MX - Messico 1
PH - Filippine 1
Totale 6.446
Città #
Woodbridge 666
Fairfield 621
Ann Arbor 468
Houston 430
Chandler 429
Ashburn 320
Seattle 244
Wilmington 240
Cambridge 189
Jacksonville 187
Singapore 151
Boardman 147
Dearborn 132
Princeton 94
Dublin 87
Beijing 68
Izmir 68
Udine 55
San Diego 39
Ogden 28
Norwalk 26
Falls Church 23
New York 22
Des Moines 21
Dong Ket 20
Ottawa 18
Brussels 15
Grafing 14
Hefei 10
Santa Clara 10
Nanjing 9
Redmond 9
Warsaw 9
Jinan 8
Wuhan 8
Bologna 7
Guangzhou 7
Kunming 7
Rome 7
Toronto 7
Lappeenranta 6
Lomé 6
Milan 6
Nanchang 6
Shenzhen 6
Treviso 6
Chengdu 5
Los Angeles 5
Vicenza 5
Vienna 5
Andover 4
Chioggia 4
Frankfurt am Main 4
Helsinki 4
Munich 4
Tokyo 4
Amsterdam 3
Camponogara 3
Cividale Del Friuli 3
Hyderabad 3
Phoenix 3
Shenyang 3
Turin 3
Venezia 3
Wenzhou 3
Agugliano 2
Baotou 2
Bari 2
Conegliano 2
Edinburgh 2
Fuzhou 2
Indiana 2
Latina 2
Latisana 2
Luxembourg 2
Mestre 2
Montreal 2
Noida 2
Papariano 2
Pignone 2
Pomezia 2
Reggiolo 2
Rio Saliceto 2
Schiavon 2
Strigno 2
Trieste 2
Washington 2
Wembley 2
West Jordan 2
Xian 2
Zurich 2
Aiello Del Friuli 1
Arsiero 1
Budapest 1
Buffalo 1
Changsha 1
Codroipo 1
Deventer 1
Edmonton 1
Eindhoven 1
Totale 5.088
Nome #
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 151
Fluocinolone acetonide for the treatment of diabetic macular edema 134
A case of CRB1-negative Coats-like retinitis pigmentosa 134
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 129
Proliferative Diabetic Retinopathy: Treatment Update 129
Advances in pharmacotherapy for wet age-related macular degeneration 122
Triple therapy for corneal neovascularization: A case report 121
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 120
Neovascular age-related macular degeneration 119
Online optical coherence tomography during subthreshold laser irradiation 118
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 116
Optical coherence tomography angiography findings in diabetic retinopathy 114
Fundus autofluorescence applications in retinal imaging 113
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 113
Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization. 113
Dexamethasone implant in diabetic macular edema in real-life situations 111
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 109
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: An in vitro study 108
Update on combination therapy in wet age-related macular degeneration 107
Intravitreal injections: a healthcare failure modes and effects analysis. 105
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 105
Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery 103
Major ocular complications after organ transplantation 103
Functional and morphological changes after macular pucker surgery: An optical coherence tomography and microperimetric study 103
Selective laser trabeculoplasty 102
Drug safety evaluation of intravitreal triamcinolone acetonide 102
Author’s response 101
Non-proliferative diabetic retinopathy 98
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 98
Ocular complications after hand transplantation 97
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: One-year follow-up 96
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: Impact of different photodynamic therapy parameters 94
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study 94
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: A literature review 92
Pharmacotherapy for treatment of retinal vein occlusion. 90
Triamcinolone acetonide for the treatment of diabetic macular oedema 86
null 85
Trauma and emergencies 84
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 84
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 83
Diabetic macular edema 80
Intravitreal steroids for the treatment of retinal diseases. 79
One-year outcome of ranibizumab for neovascular age-related macular degeneration: a thorough analysis in a real-world clinical setting. 79
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 77
Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion. 75
Experience with the Pascal® photocoagulator: An analysis of over 1200 laser procedures with regard to parameter refinement 75
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 74
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 72
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 69
Regression of diabetic macular edema after subcutaneous exenatide. 68
Steroids in a Combination Strategy 66
Vascular Anomalies of the Fundus Oculi: Diagnosis and Treatment 66
null 61
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 61
Macular pucker 57
Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study 57
Impact on quality of life 49
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 48
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 45
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 43
Subthreshold laser 39
Edema maculare post occlusione venosa 37
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 37
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 36
Occhio 35
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 34
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 34
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 33
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 33
Color fundus autofluorescence to determine activity of macular neovascularization in age-related macular degeneration 33
The role of steroids in the treatment of diabetic macular edema 32
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 32
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 32
Present Status of Laser Therapy: Role of Subthreshold Laser 31
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 29
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 29
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 28
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 28
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 28
OCT angiography in chronic central serous chorioretinopathy 27
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 27
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 26
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 26
Stem cell therapy in retinal diseases: current evidence 22
The Present and Future of Optic Pathway Glioma Therapy 21
Diabetic macular edema 21
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study 21
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 20
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose 19
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 19
Macular Holes 17
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 17
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 17
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 16
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 15
Surgical Management for Diabetic Macular Edema 13
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 13
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 13
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 13
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 13
Totale 6.603
Categoria #
all - tutte 27.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.222 0 0 0 0 131 259 176 185 139 127 34 171
2020/2021926 43 110 56 121 45 92 38 98 124 36 100 63
2021/2022655 31 41 21 18 25 39 54 34 18 119 134 121
2022/2023925 120 64 12 140 91 234 0 70 119 9 32 34
2023/2024323 66 22 6 8 40 35 13 28 45 21 2 37
2024/2025390 37 121 111 87 34 0 0 0 0 0 0 0
Totale 6.712